Cancer Research Antibodies

Designed for researchers working with antibodies in cancer research, these posters highlight critical pathways and mechanisms, from immune checkpoints to cytokine networks, to support informed study design and biological interpretation across experimental systems.

Scientists engaged in cancer drug development utilize a range of model systems, including various in vivo, in vitro, and emerging approaches. Antibodies play an important role in this research and discovery process, with researchers facing questions about how to match model systems to applications and models to antibodies.

Download the Poster

Explore expert perspectives on cancer immunology, tumor microenvironment biology, and antibody-based research. Our articles examine how ultra-pure, low-endotoxin functional antibodies minimize experimental artifacts and support reproducible, biologically meaningful outcomes across cancer research workflows.

Publication Date: 29 June 2026

Emerging evidence suggests that type 2 immune signaling may help restore exhausted CD8+ T cell function and improve responses to multiple immunotherapy modalities. This application highlight explores the mechanistic studies and functional antibody strategies used to investigate these pathways.

Read More

Publication Date: 28 June 2026

Neutrophils can both promote and suppress anti-tumor immunity, making mechanistic interpretation of depletion studies increasingly complex. Learn how complementary antibody strategies help researchers distinguish broad depletion effects from subset-specific biology.

Read More

Publication Date: 27 June 2026

Tumor-associated macrophages are key regulators of immune suppression and immunotherapy response, but not all myeloid populations respond equally to depletion. Explore how anti-CSF1R antibodies are being used to dissect macrophage biology and guide combination immunotherapy studies.

Read More

Publication Date: 24 June 2026

Bone metastases are increasingly recognized as active regulators of systemic anti-tumor immunity rather than passive sites of disease. This application highlight examines functional antibody approaches used to investigate osteoclast biology, checkpoint resistance, and immune regulation across metastatic compartments.

Read More

Publication Date: 10 April 2026

Cancer research is entering a new era of precision and complexity, driven by advances in immunotherapy and translational science. This article highlights key insights from leading experts on how emerging therapeutic strategies are reshaping cancer research from preclinical discovery to clinical impact.

Read More

Publication Date: 25 November 2025

The tumor microenvironment shapes cancer progression, immune evasion, and therapeutic response. This article explores how immune cells, cytokines, and checkpoint pathways interact within the TME, and how functional antibodies enable precise interrogation of these complex dynamics in cancer research.

Read More

Publication Date: 7 February 2024

Checkpoint blockade studies depend on selecting the right antibody clone for your model. This article compares commonly used murine PD-1 and PD-L1 antibodies, highlighting differences in binding affinity, blocking activity, and functional outcomes to help guide more informed experimental design in immuno-oncology research.

Read More

Discover expert-led webinars exploring cancer immunology, tumor microenvironment biology, and antibody-based research. These on-demand videos feature scientific discussions on how ultra-pure, low-endotoxin functional antibodies minimize experimental artifacts and support reproducible, biologically meaningful outcomes across cancer research workflows.

PD-1 signaling is a central regulator of T-cell function and a cornerstone of cancer immunotherapy. In this webinar, Dr. Gordon Freeman explores how PD-1 blockade antibodies are used to dissect checkpoint biology, study T-cell exhaustion, and model immune responses in preclinical cancer research.

Watch Now